262 related articles for article (PubMed ID: 25885449)
21. Inhibition of AKT Sensitizes Cancer Cells to Antineoplastic Drugs by Downregulating Flap Endonuclease 1.
Zhu H; Wu C; Wu T; Xia W; Ci S; He W; Zhang Y; Li L; Zhou S; Zhang J; Edick AM; Zhang A; Pan FY; Hu Z; He L; Guo Z
Mol Cancer Ther; 2019 Dec; 18(12):2407-2420. PubMed ID: 31467180
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of FEN1 promotes DNA damage and enhances chemotherapeutic response in prostate cancer cells.
Wang Z; Yong C; Fu Y; Sun Y; Guo Z; Liu SB; Hu Z
Med Oncol; 2023 Jul; 40(8):242. PubMed ID: 37452976
[TBL] [Abstract][Full Text] [Related]
23. rs2294008T, a risk allele for gastric and gallbladder cancers, suppresses the PSCA promoter by recruiting the transcription factor YY1.
Saeki N; Ono H; Yanagihara K; Aoyagi K; Sasaki H; Sakamoto H; Yoshida T
Genes Cells; 2015 May; 20(5):382-91. PubMed ID: 25727947
[TBL] [Abstract][Full Text] [Related]
24. MZF1 possesses a repressively regulatory function in ERCC1 expression.
Yan QW; Reed E; Zhong XS; Thornton K; Guo Y; Yu JJ
Biochem Pharmacol; 2006 Mar; 71(6):761-71. PubMed ID: 16426580
[TBL] [Abstract][Full Text] [Related]
25. Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis.
Wang K; Xie C; Chen D
Int J Mol Med; 2014 May; 33(5):1268-74. PubMed ID: 24590400
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
27. FEN1 is overexpressed in testis, lung and brain tumors.
Nikolova T; Christmann M; Kaina B
Anticancer Res; 2009 Jul; 29(7):2453-9. PubMed ID: 19596913
[TBL] [Abstract][Full Text] [Related]
28. Identification of human flap endonuclease 1 (FEN1) inhibitors using a machine learning based consensus virtual screening.
Deshmukh AL; Chandra S; Singh DK; Siddiqi MI; Banerjee D
Mol Biosyst; 2017 Jul; 13(8):1630-1639. PubMed ID: 28685785
[TBL] [Abstract][Full Text] [Related]
29. Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.
Bonavida B; Baritaki S
Nitric Oxide; 2011 Jan; 24(1):1-7. PubMed ID: 20933602
[TBL] [Abstract][Full Text] [Related]
30. Characterization of human collagen XVIII promoter 2: interaction of Sp1, Sp3 and YY1 with the regulatory region and a SNP that increases transcription in hepatocytes.
Armelin-Correa LM; Lin CJ; Barbosa A; Bagatini K; Winnischofer SM; Sogayar MC; Passos-Bueno MR
Matrix Biol; 2005 Dec; 24(8):550-9. PubMed ID: 16229994
[TBL] [Abstract][Full Text] [Related]
31. Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer.
Huerta-Yepez S; Baritaki S; Baay-Guzman G; Hernandez-Luna MA; Hernandez-Cueto A; Vega MI; Bonavida B
Nitric Oxide; 2013 Feb; 29():17-24. PubMed ID: 23246440
[TBL] [Abstract][Full Text] [Related]
32. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
[TBL] [Abstract][Full Text] [Related]
33. Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer.
Sato M; Girard L; Sekine I; Sunaga N; Ramirez RD; Kamibayashi C; Minna JD
Oncogene; 2003 Oct; 22(46):7243-6. PubMed ID: 14562054
[TBL] [Abstract][Full Text] [Related]
34. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
35. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
[TBL] [Abstract][Full Text] [Related]
36. Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27.
Wan M; Huang W; Kute TE; Miller LD; Zhang Q; Hatcher H; Wang J; Stovall DB; Russell GB; Cao PD; Deng Z; Wang W; Zhang Q; Lei M; Torti SV; Akman SA; Sui G
Am J Pathol; 2012 May; 180(5):2120-33. PubMed ID: 22440256
[TBL] [Abstract][Full Text] [Related]
37. The FEN1 L209P mutation interferes with long-patch base excision repair and induces cellular transformation.
Sun H; He L; Wu H; Pan F; Wu X; Zhao J; Hu Z; Sekhar C; Li H; Zheng L; Chen H; Shen BH; Guo Z
Oncogene; 2017 Jan; 36(2):194-207. PubMed ID: 27270424
[TBL] [Abstract][Full Text] [Related]
38. Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer.
Liu L; Zhou C; Zhou L; Peng L; Li D; Zhang X; Zhou M; Kuang P; Yuan Q; Song X; Yang M
Carcinogenesis; 2012 Jan; 33(1):119-23. PubMed ID: 22072618
[TBL] [Abstract][Full Text] [Related]
39. Role of FEN1 S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development.
Zhou L; Dai H; Wu J; Zhou M; Yuan H; Du J; Yang L; Wu X; Xu H; Hua Y; Xu J; Zheng L; Shen B
FASEB J; 2017 Jan; 31(1):132-147. PubMed ID: 27694478
[TBL] [Abstract][Full Text] [Related]
40. A one-pot transcriptional assay method that detects the tumor biomarker FEN1 based on its flap cleavage activity.
Song DY; Park YJ; Kim DM
Anal Chim Acta; 2023 Nov; 1282():341928. PubMed ID: 37923413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
